Children's Ibuprofen Oral Suspension — Class II drug recall D-0390-2026
Ongoing recall by STRIDES PHARMA INC, reported 2026-03-25, distributed nationwide. Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the pro
| Recall number | D-0390-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | STRIDES PHARMA INC, Bridgewater, NJ, United States |
| Recall initiated | 2026-03-02 |
| Classified | 2026-03-16 |
| Reported by FDA | 2026-03-25 |
| Distributed | Nationwide (US) |
| Quantity | 89,592 bottles |
| NDC | 51672-5321, 51672-5321-01, 51672-5321-08 |
| Lot numbers | 7261973A, 7261974A |
| Expiration dates | 2027-01-31 |
Product
Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.
Reason for recall
Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0390-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.